Dublin, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/55xd3g/global_single) has announced the addition of the "Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018" report to their offering.
Single Nucleotide Polymorphism (SNP) genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for whole-genome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study.
It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and analysis such as SNP GeneChips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex, and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight.
The analysts forecast the Global SNP Genotyping and Analysis market to grow at a CAGR of 20.65 percent over the period 2013-2018.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Technology
08. Market Segmentation by Application
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
18. Key Vendor Analysis
19. Other Reports in this Series
Companies Mentioned:
- Affymetrix Inc.
- Illumina Inc.
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Douglas Scientific Llc.
- Fluidigm Corp.
- Luminex Corp.
- PREMIER Biosoft Intl.
- Promega Corp
- Qiagen N. V.
- Sequenom Inc.
- WaferGen Biosystems Inc.
For more information visit http://www.researchandmarkets.com/research/55xd3g/global_single